Back to results
TerminatedPhase 2

Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer

NCT00574236

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Wisconsin Paul P. Carbone Comprehensive Cancer Center

Madison, Wisconsin, United States

View on ClinicalTrials.gov
Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer — TrialFind